Active Ingredient: AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
Proprietary Name: DYMISTA
Dosage Form; Route of Administration: SPRAY, METERED; NASAL
Strength: 0.137MG/SPRAY;0.05MG/SPRAY
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N202236
Product Number: 001
Approval Date: May 1, 2012
Applicant Holder Full Name: MYLAN SPECIALTY LP
Marketing Status:
Prescription
Patent and Exclusivity Information
